Výsledky vyhledávání

The Burden of Residual SymptOms That Complicate the Life of Patients Who Have Suffered a new Coronavirus Infection (THROW study)

Autor: Ya. A. Orlova, Yu. V. Mareev, V. Yu. Mareev, A. G. Plisyk, Yu. L. Begrambekova, Z. A. Akopyan, D. M. Sakaeva, D. D. Loginova, A. S. Shurygina, A. A. Kamalov

Publikováno v: Kardiologiia. 62(10)

Aim To evaluate the prevalence of residual symptoms in patients hospitalized for novel coronavirus infection at 8 months after discharge and the severity of such symptoms depending on demographic characteristics, concurrent diseases, and specific fea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6650bf31cb8b03585a876df9efe930f2
https://pubmed.ncbi.nlm.nih.gov/36384406

Zobrazit plný text záznamu

Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study

Autor: A A Kamalov, Yu V Mareev, Elena Mershina, V Yu Mareev, P V Pakhomov, A G Plisyk, Yu L Begrambekova, Ya A Orlova, Z A Akopyan

Publikováno v: Kardiologiia. 61:28-39

Actuality One of the most widely discussed treatments for patients with COVID-19, especially at the beginning of the epidemy, was the use of the antimalarial drug hydroxychloroquine (HCQ). The first small non-randomized trials showed the ability of H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b12740da333390dac2c9443918edd5
https://doi.org/10.18087/cardio.2021.2.n1548

Zobrazit plný text záznamu

Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study

Publikováno v: Kardiologiia. 61:15-27

ActualityThe course of the novel coronavirus disease (COVID-19) is unpredictable. It manifests in some cases as increasing inflammation to even the onset of a cytokine storm and irreversible progression of acute respiratory syndrome, which is associa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eae84661d626c2ecb74810b8e6b0e324
https://doi.org/10.18087/cardio.2021.2.n1560

Zobrazit plný text záznamu

Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial 'BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)'

Autor: A V Potapenko, Z A Akopyan, A A Fuks, Elena Mershina, V Yu Mareev, Yu L Begrambekova, D A Asratyan, M M Bulanova, S T Matskeplishvili, L M Samokhodskaya, P S Malakhov, A A Kamalov, Valentin Sinitsyn, A G Plisyk, E M Seredenina, E P Pavlikova, Ya A Orlova, Yu V Mareev

Publikováno v: Kardiologiia. 60:4-15

The article focuses on effective treatment of the novel coronavirus infection (COVID-19) at early stages and substantiates the requirement for antiviral therapy and for decreasing the viral load to prevent the infection progression. The absence of a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f509b4b1c06a4242e5c46c8a9f64655f
https://doi.org/10.18087/cardio.2020.8.n1307

Zobrazit plný text záznamu

[Features of a new corOnavirUs infection course and optioNs therapy DEpending on the andRogenic status (FOUNDER): androgenic status in men with COVID-19 and its relationship with the disease severity]

Autor: A A, Kamalov, V Yu, Mareev, Ia A, Orlova, D A, Ohobotov, Yu V, Mareev, Yu L, Begrambekova, Z Sh, Pavlova, A G, Plisyk, L M, Samokhodskaya, E A, Mershina, A A, Tretyakov, O Yu, Nesterova, A S, Shurygina

Publikováno v: Urologiia (Moscow, Russia : 1999). (6)

Analysis of androgen status in men hospitalized with a moderate COVID-19 and its relationship with the severity of the disease.The study included 152 males with a confirmed diagnosis of COVID-19 based on the results of a positive PCR for the SARS-CoV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ac525f6d1a57ff9d55300e7a6299e383
https://pubmed.ncbi.nlm.nih.gov/34967512

Zobrazit plný text záznamu

[Results of Open-Label non-Randomized Comparative Clinical Trial: 'BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)]

Publikováno v: Kardiologiia. 60(11)

Introduction The aim of this study was to assess the efficacy and safety of a combination of bromhexine at a dose of 8 mg 4 times a day and spironolactone 50 mg per day in patients with mild and moderate COVID 19.Material and methods It was an open,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f1b628c587ee49165802e242b2dc989
https://pubmed.ncbi.nlm.nih.gov/33487145

Zobrazit plný text záznamu

[Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)]

Autor: A V Potapenko, V Yu Mareev, Yu L Begrambekova, P S Malakhov, E A Zhdanova, А А Kamalov, A G Plisyk, L M Samokhodskaya, Yu V Mareev, E A Shatochina, Valentin Sinitsyn, Е А Mershina, Z A Akopyan, Ya A Orlova, S T Matskeplishvili, E P Pavlikova, E M Seredenina, D A Asratyan

Publikováno v: Kardiologiia. 60(9)

The article is devoted to the treatment of the new coronavirus infection (COVID-19) in the advanced stages of the disease. The types of response of the immune system to the viral load of SARS-CoV-2 with the start of the inflammation process are consi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802faf947d6de81166c95dbdf57b6b56
https://pubmed.ncbi.nlm.nih.gov/33131470

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání